Advanced Dual-Release Delivery Systems for Supplement Manufacturing
Separate incompatible ingredients, enable multi-phase release, and create premium supplement experiences through advanced capsule-in-capsule manufacturing.
What Is Capsule-in-Capsule Technology?
Capsule-in-capsule technology is an advanced oral dosage form in which a smaller, prefilled inner capsule is inserted into a larger outer capsule. The two compartments can contain different ingredients, different physical states (liquid, powder, beadlets), or different release profiles—enabling formulations that are impossible with standard single-capsule designs.
How It Works
OUTER CAPSULE – Liquid / Powder / Beadlets
INNER CAPSULE – Powder (Probiotic / Delayed- Release Actives )
Release Timeline
| Phase | Time | What Happens | Typical Ingredients |
| Immediate Release | 0–15 min | Outer capsule dissolves in stomach | Vitamins, minerals, oils, amino acids |
| Protection Phase | 15–45 min | Inner capsule transits through stomach | — |
| Secondary Release | 45–120 min | Inner capsule dissolves in intestine | Probiotics, NMN, enzymes, curcumin |
This architecture enables four critical capabilities that standard capsules cannot provide:
| Capability | Example Application |
| Liquid + Powder | Omega-3 oil (outer) + NMN powder (inner) |
| Powder + Powder Separation | Probiotic (inner) + botanical extract (outer) |
| Immediate + Delayed Release | Vitamin C (immediate) + Curcumin (delayed) |
| Incompatible Coexistence | Acid-sensitive enzymes + mineral co-factors |
Why Brands Choose Capsule-in-Capsule Technology
Supplement brands and OEM partners face five recurring formulation challenges that standard capsules cannot solve. Capsule-in-capsule technology provides a direct solution for each:
| Formulation Challenge | Capsule-in-Capsule Solution |
| Oil and powder cannot be blended efficiently | Separate oil and powder into independent compartments—no emulsification required |
| Probiotics lose viability in stomach acid | Enteric-coated inner capsule protects viable cells; survival up to 97% vs. <1% unprotected |
| Ingredients react or degrade during storage | Physical barrier prevents moisture migration, oxidation, and chemical interaction |
| Multiple supplements required per serving | Consolidate 2–4 actives into a single capsule—improves compliance and reduces SKU count |
| Need premium product differentiation | Unique dual-capsule appearance creates strong shelf presence and supports premium pricing |
Traditional single-capsule designs force brands to either (1) separate incompatible ingredients into multiple SKUs, (2) compromise stability by mixing incompatible actives, or (3) accept poor bioavailability for acid-sensitive compounds. Capsule-in-capsule eliminates all three trade-offs.
Capsule-in-Capsule vs. Standard Capsules
| Features | Standard Capsule | Capsule-in-Capsule |
| Ingredient Separation | ❌ No | ✅ Yes — physical barrier |
| Dual Release | ❌ Single profile | ✅ Independent profiles |
| Liquid + Powder | ❌ Requires emulsification | ✅ Natural coexistence |
| Gastric Protection | ❌ Entire capsule coated or none | ✅ Inner capsule independently enteric-coated |
| Probiotic Viability | <1% without protection | Up to 97% with enteric inner capsule |
| Premium Positioning | Limited | Excellent — visual differentiation |
| Consumer Convenience | Multiple capsules per serving | Single capsule, multiple actives |
Key Benefits
| Benefit | Technical Mechanism | Business Impact |
| Ingredient Stability | Physical separation prevents moisture migration, oxidation, and chemical interaction | Extended shelf life; reduced overbuilding |
| Dual Release Timing | Outer capsule = immediate; inner capsule = delayed/intestinal | Optimal nutrient timing; supports efficacy claims |
| Gastric Protection | Inner capsule can be enteric-coated (pH ≥5.5 release) | Protects probiotics, enzymes, peptides, NMN |
| Formulation Freedom | Combines liquid, powder, beadlets in one unit | Enables previously impossible combinations |
| Premium Positioning | Distinctive visual appearance | Higher perceived value; supports premium pricing |
| Consumer Compliance | Consolidates multiple supplements into one capsule | Fewer pills per day; higher retention |
Most Popular Applications
Longevity Supplements
Longevity formulations present unique challenges: NMN is hygroscopic and acid-sensitive; resveratrol has poor water solubility and benefits from lipid co-delivery; urolithin A requires targeted release; spermidine degrades when exposed to moisture. Capsule-in-capsule technology addresses all four:
| Stack | Outer Capsule | Inner Capsule | Why Capsule-in-Capsule |
| NMN + Resveratrol | Resveratrol in oil base | NMN powder (protected from moisture/acid) | NMN is hygroscopic; resveratrol needs lipid co-delivery |
| Urolithin A + NMN | Urolithin A (low solubility, oil-based) | NMN powder | Complementary mitochondrial support |
| Spermidine + Polyphenols | Polyphenol extract | Spermidine (moisture-sensitive) | Prevents degradation during storage |
| Mitochondrial Complex | CoQ10 oil + PQQ | NAD+ precursor (NMN/NR) | Oil-soluble + water-soluble separation |
Why capsule-in-capsule is ideal for longevity:
- Oil-soluble ingredients(resveratrol, CoQ10, omega-3) in the outer capsule for immediate absorption
- Moisture-sensitive ingredients(NMN, spermidine) in the inner capsule with desiccant protection
- Immediate and delayed release optimization— outer for fast-acting actives, inner for sustained delivery
- Single-dose longevity stacks— consolidate 3–4 premium ingredients into one daily capsule
Related: NMN Supplement Manufacturing · Urolithin A Formulation · Spermidine Stability
Probiotic Protection
Probiotics face three critical threats: gastric acid (pH 1.5–3.5), digestive enzymes, and bile salts. Without protection, viable cell survival in the stomach is <1%. Clinical studies show that enteric-coated inner capsules can maintain up to 97% viability after gastric exposure, compared to unprotected powder formulations.
Capsule-in-capsule enables synbiotic formulations (probiotic + prebiotic) with natural separation:
| Compartment | Contents | Release Site |
| Outer capsule | Prebiotic fiber (inulin, FOS, GOS) | Stomach / small intestine |
| Inner capsule | Probiotic strains (enteric-coated) | Colon |
This ensures the prebiotic reaches the colon first, creating the optimal environment for probiotic colonization.
Related: Probiotic Capsule Manufacturing · Synbiotic Formulation Development
Other High-Demand Categories
| Category | Typical Combinations | Benefit |
| Women’s Health | Evening primrose oil (outer) + D-chiro-inositol (inner) | Oil + powder without emulsification |
| Beauty From Within | Astaxanthin oil (outer) + Collagen peptides (inner) | Protects moisture-sensitive collagen |
| Sports Nutrition | BCAAs (outer, immediate) + HMB (inner, delayed) | Optimizes performance + recovery timing |
| Cognitive Health | Omega-3 DHA (outer) + Citicoline (inner) | Lipid-soluble + water-soluble separation |
| Sleep Support | Magnesium glycinate (outer, immediate) + Melatonin (inner, delayed) | Dual-phase sleep support |
| Joint Health | Curcumin oil (outer) + UC-II collagen (inner) | Oil-based absorption + protected peptides |
Compatible Fill Formats
| Inner Capsule | Outer Capsule | Application Example |
| Powder | Oil | NMN + Omega-3 |
| Powder | Powder | Probiotic + botanical extract |
| Beadlets | Powder | Enzyme + mineral complex |
| Delayed-release capsule | Oil | Enteric enzymes + lipid co-factors |
| Probiotic capsule | Prebiotic blend | Synbiotic formula |
| Pellets | Semi-solid | Multi-phase botanical stack |
Popular Capsule-in-Capsule Formula Concepts
The following formulations represent the most requested capsule-in-capsule concepts from OEM and private-label partners. Each is designed to solve a specific formulation challenge while maximizing consumer appeal and manufacturing feasibility.
Longevity Stack
| Compartment | Ingredients | Function |
| Outer Capsule | Resveratrol, CoQ10 (oil-based) | Immediate-release antioxidant + mitochondrial support |
| Inner Capsule | NMN, PQQ | Delayed-release NAD+ precursor + mitochondrial biogenesis |
| Benefit | Single-dose longevity stack with optimal absorption timing for both oil-soluble and water-soluble actives |
Gut Health Synbiotics
| Compartment | Ingredients | Function |
| Outer Capsule | Inulin, FOS (prebiotic fiber) | Immediate-release to nourish gut microbiome |
| Inner Capsule | Lactobacillus, Bifidobacterium (enteric-coated) | Delayed-release to colon for live cell delivery |
| Benefit | True synbiotic with prebiotic reaching the colon before probiotic release |
Sleep Support Formula
| Compartment | Ingredients | Function |
| Outer Capsule | Magnesium glycinate | Immediate-release relaxation support |
| Inner Capsule | Melatonin (delayed-release) | Sustained-release sleep onset and maintenance |
| Benefit | Dual-phase sleep support: calm the body first, then sustain sleep architecture |
Women’s Health Formula
| Compartment | Ingredients | Function |
| Outer Capsule | Evening primrose oil | Immediate-release essential fatty acids |
| Inner Capsule | D-Chiro-inositol | Delayed-release insulin sensitivity support |
| Benefit | Oil-soluble + water-soluble combination without emulsification compromise |
Sports Recovery Stack
| Compartment | Ingredients | Function |
| Outer Capsule | BCAAs, electrolytes | Immediate-release intra-workout support |
| Inner Capsule | HMB, digestive enzymes (enteric-coated) | Delayed-release muscle recovery + nutrient absorption |
| Benefit | Performance phase + recovery phase in one capsule |
Cognitive Nootropics
| Compartment | Ingredients | Function |
| Outer Capsule | Omega-3 DHA, phosphatidylserine | Immediate-release lipid-based brain fuel |
| Inner Capsule | Citicoline, bacopa extract | Delayed-release cholinergic + adaptogenic support |
| Benefit | Lipid-soluble nootropics + water-soluble actives in optimal delivery format |
Have a custom formulation idea? Contact our formulation team to evaluate feasibility, MOQ, and development timeline.
Development Feasibility Guide
| Formula Type | Feasibility | Notes |
| Powder + Powder | ⭐⭐⭐⭐⭐ Excellent | Most common; full separation |
| Powder + Oil | ⭐⭐⭐⭐⭐ Excellent | Ideal for lipid-soluble + water-soluble |
| Oil + Oil | ⭐⭐⭐⭐ Good | Requires viscosity matching |
| Probiotic + Prebiotic | ⭐⭐⭐⭐⭐ Excellent | Synbiotic; moisture isolation critical |
| NMN + Resveratrol | ⭐⭐⭐⭐⭐ Excellent | High-demand longevity stack |
| Enzyme + Mineral | ⭐⭐⭐⭐⭐ Excellent | Acid-sensitive enzymes protected |
| Peptide + Botanical | ⭐⭐⭐⭐ Good | Peptide stability requires validation |
| Liquid + Liquid (different phases) | ⭐⭐⭐ Moderate | Requires immiscibility or encapsulation |
Manufacturing Specifications
Capsule Size Options
| Outer Size | Inner Size | Typical Fill Volume | Best For |
| Size 00 | Size 3 or 4 | 600–800 mg outer + 200–300 mg inner | High-dose formulations |
| Size 0 | Size 4 or 5 | 400–600 mg outer + 150–200 mg inner | Standard dual-release |
| Size 1 | Size 5 | 250–400 mg outer + 100–150 mg inner | Premium, lower-dose products |
Custom sizes and polymer selections (gelatin, HPMC, pullulan) available for vegan, kosher, and halal requirements.
Advanced Manufacturing Capabilities
- Dual-compartment filling systems— Integrated inner capsule production, inspection, and outer encapsulation in a single validated line
- Vision inspection systems— 100% verification of inner capsule presence, orientation, and integrity within the outer capsule
- Advanced capsule sealing technology— LEMS® (Liquid Encapsulation Micro-Spray) and standard banding for liquid-filled outer capsules
- Enteric coating capabilities— pH-dependent coating (Eudragit, HPMC-AS) for targeted intestinal or colonic release
- Stability validation support— ICH Q1A(R2) compliant accelerated and real-time stability programs
- Accelerated compatibility testing— Binary and ternary mixture stress testing (40°C/75% RH) before prototype development
Quality Control Standards
| Test Category | Standard | Purpose |
| Capsule Integrity | Visual inspection 100% + leak testing | No cracks, splits, or seal defects |
| Fill Weight | Inner: ±3%; Outer: ±5%; Total: ±4% | Dose uniformity |
| Dissolution | USP <711> / <724> | Verify independent release kinetics |
| Enteric Coating | USP <701> (2h acid, 45min buffer) | Gastric resistance validation |
| Stability | ICH Q1A(R2) — 25°C/60% RH, 40°C/75% RH | Shelf-life establishment |
| Moisture | Karl Fischer + water activity (aw) | Critical for probiotics (aw < 0.25) |
| Microbiology | USP <61> / <62> | Total count, yeast/mold, specified organisms |
| Probiotic Viability | CFU/g at release + stability timepoints | Label claim compliance |
Typical Shelf Life by Category
| Product Type | Shelf Life | Key Stability Indicator |
| Standard dual-release | 24–36 months | Potency retention ≥90% |
| Probiotic | 18–24 months | Viable cells ≥ label claim at expiry |
| NMN-containing | 24 months | NMN purity ≥95% at expiry |
| Oil + powder | 24 months | Peroxide value + potency within spec |
OEM & ODM Development Process
| Phase | Timeline | Deliverables |
| 1. Concept Evaluation | 2–4 weeks | Market fit, regulatory pathway, preliminary cost model |
| 2. Formula Design | 4–6 weeks | Ingredient sourcing, excipient compatibility, prototype formula |
| 3. Compatibility Assessment | 2–4 weeks | Stress testing (40°C/75% RH), shell compatibility verification |
| 4. Prototype Development | 4–6 weeks | 1,000–5,000 units, fill weight optimization, dissolution testing |
| 5. Pilot Production | 6–8 weeks | 10,000–50,000 units, process validation (IQ/OQ/PQ), stability initiation |
| 6. Stability Study | 6–24 months | Real-time + accelerated data, shelf-life claim establishment |
| 7. Commercial Manufacturing | Ongoing | Batch production, continuous QC, annual stability commitment |
MOQ & Lead Time
MOQ depends on formula complexity, capsule size, coating requirements, and packaging format. Commercial projects typically start from medium-to-large production volumes.
| Development Type | Lead Time |
| Existing formula (standard dual-release) | 6–8 weeks |
| Customized formula (known ingredients) | 10–14 weeks |
| New release profile / novel combination | 16–24 weeks |
| Custom capsule colors / branding | +2–4 weeks |
Early engagement during the concept phase optimizes both MOQ and cost structure. Contact us for a project evaluation.
Why Develop with KS Nutripharma
Formulation Expertise
- Longevity supplement stacks (NMN, NAD+ precursors, sirtuin activators)
- Probiotic delivery systems (single-strain, multi-strain, synbiotics)
- Women’s health (hormone balance, prenatal, menopause support)
- Sports nutrition (pre-workout, recovery, protein co-delivery)
- Cognitive health (nootropic stacks, lipid + water-soluble combinations)
- Beauty from within (collagen, hyaluronic acid, carotenoid systems)
Manufacturing Capability
- 81,000㎡GMP-certified production facility
- 12integrated production lines
- 2,000,000+softgels daily capacity
- 5,000,000+capsules daily capacity
- 12,000,000+tablets daily capacity
- Global export documentation (FDA, EFSA, TGA, Health Canada, APAC)
IP & Partnership Protection
- NDA support for all development projects
- Formula confidentiality agreements
- Exclusive manufacturing options for proprietary formulations
- Custom release profile development (immediate, delayed, enteric, colonic)
Frequently Asked Questions
What is capsule-in-capsule technology?
An advanced dosage form where a smaller inner capsule is inserted into a larger outer capsule, enabling two compartments with independent ingredients, physical states, and release profiles.
How does dual release work?
The outer capsule dissolves in the stomach (5–15 minutes) for immediate release. The inner capsule—optionally enteric-coated—transits to the intestine and releases at pH ≥5.5, creating a two-phase delivery from a single dose.
Is it better than standard capsules?
For formulations requiring ingredient separation, dual-release timing, or gastric protection, yes. For simple single-ingredient products, standard capsules remain cost-effective.
Can NMN and Resveratrol be combined in one capsule?
Yes. NMN (hygroscopic, acid-sensitive) goes in the inner capsule. Resveratrol (lipid-soluble, benefits from oil co-delivery) goes in the outer capsule. This is one of the most requested longevity stacks.
Can probiotics survive in capsule-in-capsule products?
Yes. The inner capsule can be enteric-coated to protect probiotics from gastric acid. Clinical data shows up to 97% viability survival compared to <1% for unprotected powder.
Does it improve ingredient stability?
Yes. Physical separation prevents moisture migration, oxidation, and chemical interactions between incompatible actives during storage and shelf life.
What capsule sizes are available?
Standard combinations: Outer 00 + Inner 3/4 (high-dose), Outer 0 + Inner 4/5 (standard), Outer 1 + Inner 5 (premium). Custom sizes and vegan polymers (HPMC, pullulan) available.
Can delayed-release ingredients be incorporated?
Yes. The inner capsule can be coated with enteric polymers (Eudragit, HPMC-AS) for release at specific pH thresholds (pH ≥5.5 for duodenum, pH ≥7.0 for colon).
What is the lead time?
Existing formulas: 6–8 weeks. Custom development: 10–14 weeks. Novel systems: 16–24 weeks.
Are HPMC (vegan) capsules available?
Yes. Both inner and outer capsules can be manufactured with HPMC or pullulan for vegan, kosher, and halal requirements.
Can capsule-in-capsule products be manufactured under private label?
Yes. We support private-label, white-label, and fully custom OEM/ODM development for capsule-in-capsule products.
Can you support custom capsule colors?
Yes. Custom shell colors, branding, and printing are available. Minimum volumes apply depending on color complexity.
Can you provide stability testing?
Yes. We offer full ICH Q1A(R2) stability programs including accelerated (40°C/75% RH) and real-time (25°C/60% RH) studies with interim data reports.
Can you support regulatory documentation?
Yes. We provide FDA, EFSA, TGA, Health Canada, and APAC regulatory documentation packages including COA, stability summaries, and manufacturing specifications.
Can oil and powder be combined in one capsule?
Yes. This is one of the most common and feasible capsule-in-capsule configurations. The outer capsule contains oil; the inner capsule contains powder.
Launching a Differentiated Capsule-in-Capsule Supplement
Whether you are developing:
✓ Longevity stacks — NMN, resveratrol, NAD+ precursors, mitochondrial support
✓ Synbiotic probiotics — Prebiotic + probiotic with targeted colonic delivery
✓ Delayed-release enzyme formulas — Gastric-protective enzymes for optimal intestinal activity
✓ Oil + powder combinations — Omega-3 + water-soluble actives without emulsification
✓ Premium dual-release supplements — Immediate + sustained release in a single daily dose
KS Nutripharma supports formulation development, stability evaluation, pilot production, and commercial manufacturing from concept to shelf.
[Request a Formulation Consultation →]
Last Updated: June 2026
This content is for B2B procurement and technical evaluation purposes. Supplement formulations should be developed under the guidance of qualified formulators and regulatory specialists. Individual health needs vary; consult a healthcare professional before use.
